Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Live-Cell Encapsulation Facility is Commissioned for GMP Manufacture

SILVER SPRING, Md., April 25, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
April 08, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Encapsulation Facility for Pancreatic Cancer Therapy Deemed Suitable by Thai FDA

SILVER SPRING, Md., April 08, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
March 31, 2016 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration

SILVER SPRING, Md., March 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and...
March 15, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Discusses Protection Strategy for Cancer and Diabetes Therapies

SILVER SPRING, Md., March 15, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
March 03, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Reports on Audit of Live-Cell Encapsulation Facility by Chamow & Associates

SILVER SPRING, Md., March 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and...
March 01, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Addresses Development of Targeted Cannabinoid Chemotherapy

SILVER SPRING, Md., March 01, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
February 26, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Pancreatic Cancer Treatment to Target Recently Identified Forms of Pancreatic Cancer

SILVER SPRING, Md., Feb. 26, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 24, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer

SILVER SPRING, Md., Feb. 24, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 22, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial

SILVER SPRING, Md., Feb. 22, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 10, 2016 09:32 ET | Source: PharmaCyte Biotech, Inc.

Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech

SILVER SPRING, Md., Feb. 10, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...